Evgenia Glogova

609 total citations
24 papers, 278 citations indexed

About

Evgenia Glogova is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Neurology. According to data from OpenAlex, Evgenia Glogova has authored 24 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 10 papers in Public Health, Environmental and Occupational Health and 6 papers in Neurology. Recurrent topics in Evgenia Glogova's work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Lymphoblastic Leukemia research (10 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Evgenia Glogova is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Acute Lymphoblastic Leukemia research (10 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Evgenia Glogova collaborates with scholars based in Austria, Italy and Germany. Evgenia Glogova's co-authors include Ulrike Pötschger, Christina Peters, Heidrun Boztug, Paul Veys, Isaac Yaniv, Jacek Wachowiak, Petr Sedláček, Arjan C. Lankester, Mary Slatter and Ulrike Pöetschger and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Evgenia Glogova

21 papers receiving 272 citations

Peers

Countries citing papers authored by Evgenia Glogova

Since Specialization

Citations

This map shows the geographic impact of Evgenia Glogova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evgenia Glogova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evgenia Glogova more than expected).

Fields of papers citing papers by Evgenia Glogova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evgenia Glogova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evgenia Glogova. The network helps show where Evgenia Glogova may publish in the future.

Co-authorship network of co-authors of Evgenia Glogova

This figure shows the co-authorship network connecting the top 25 collaborators of Evgenia Glogova. A scholar is included among the top collaborators of Evgenia Glogova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evgenia Glogova. Evgenia Glogova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fcγ Receptor Polymorphism in Patients with Relapsed/Refractory High-Risk Neuroblastoma Correlates with Outcomes in the SIOPEN Dinutuximab Beta Long-Term Infusion Trial 2025 ·Clinical Cancer Research ·Holger N. Lode, Nikolai Siebert, Dominique Valteau‐Couanet, Alberto Garaventa, Adela Cañete, John W. Anderson, Isaac Yaniv, (unknown), Juliet C. Gray, Thomas Klingebiel, Hans Loibner, Roberto Luksch, Carla Manzitti, Jean Michon, Cormac Owens, Ulrike Pötschger, (unknown), Evgenia Glogova, Ruth Ladenstein, (unknown)	0
2	Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group 2024 ·British Journal of Haematology ·Herbert Pichler, Petr Sedláček, Roland Meisel, Rita Beier, Maura Faraci, Krzysztof Kałwak, Marianne Ifversen, Ingo Müller, Jerry Stein, Kim Vettenranta, Gabriele Kropshofer, Alexandra Kolenová, (unknown), Evgenia Glogova, Ulrike Pöetschger, Christina Peters, Meinolf Suttorp, (unknown), Adriana Balduzzi	3
3	Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy 2023 ·Cancers ·Holger N. Lode, Ruth Ladenstein, (unknown), (unknown), Nikolai Siebert, (unknown), Karoline Ehlert, (unknown), Evgenia Glogova, Patrick Hundsdoerfer, Angelika Eggert, (unknown), Walentyna Balwierz, Aleksandra Wieczorek	2
4	Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia 2023 ·Wiener klinische Wochenschrift ·Leila Ronceray, Michael Dworzak, Karin Dieckmann, (unknown), Evgenia Glogova, Oskar A. Haas, Neil D. Jones, Karin Nebral, (unknown), Thomas Lion, Bernhard Meister, Renate Panzer‐Grümayer, Sabine Strehl, Christina Peters, Ulrike Pötschger, Christian Urban, Georg Mann, Andishe Attarbaschi, (unknown)	2
5	The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG 2020 ·Bone Marrow Transplantation ·Jean‐Hugues Dalle, Adriana Balduzzi, Peter Bader, Anna Pieczonka, Isaac Yaniv, Arjan C. Lankester, Marc Bierings, Akif Yeşilipek, Petr Sedláček, Marianne Ifversen, Peter Švec, Jacek Toporski, (unknown), Jacek Wachowiak, Evgenia Glogova, Ulrike Pöetschger, Christina Peters	9
6	Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study 2019 ·Biology of Blood and Marrow Transplantation ·Adriana Balduzzi, Jean‐Hugues Dalle, Jacek Wachowiak, Isaac Yaniv, Akif Yeşilipek, Petr Sedláček, Marc Bierings, Marianne Ifversen, Sabina Sufliarska, Krzysztof Kałwak, Arjan Lankester, Jacek Toporski, (unknown), Evgenia Glogova, Ulrike Pöetschger, Christina Peters	25
7	Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes 2018 ·Biology of Blood and Marrow Transplantation ·Jean‐Hugues Dalle, Adriana Balduzzi, Peter Bader, Arjan C. Lankester, Isaac Yaniv, Jacek Wachowiak, Anna Pieczonka, Marc Bierings, Akif Yeşilipek, Petr Sedláček, Marianne Ifversen, Sabina Sufliarska, Jacek Toporski, Evgenia Glogova, Ulrike Pöetschger, Christina Peters	20
8	Cost-Effectiveness of Defibrotide in the Prophylaxis of Veno-Occlusive Disease after Pediatric Allogeneic Stem Cell Transplantation 2017 ·Biology of Blood and Marrow Transplantation ·Herbert Pichler, (unknown), Gernot Engstler, Ulrike Pöetschger, Evgenia Glogova, (unknown), Manuel de Mora Martín, (unknown), Volker Witt, Wolfgang Holter, Susanne Matthes‐Martin	9
9	Phase II clinical trial with long-term infusion of anti-GD₂ antibody ch14.18/CHO in combination with interleukin-2 (IL2) in patients with high risk neuroblastoma. 2016 ·Journal of Clinical Oncology ·Holger N. Lode, Dominique Valteau‐Couanet, (unknown), Carla Manzitti, Juliet C. Gray, Victoria Castel, Isaac Yaniv, Hans Loibner, Nikolai Siebert, Evgenia Glogova, Ulrike Pöetschger, Ruth Ladenstein, (unknown)	4
10	Peripheral blood late mixed chimerism in leucocyte subpopulations following allogeneic stem cell transplantation for childhood malignancies: does it matter? 2016 ·British Journal of Haematology ·Herbert Pichler, G. Fritsch, Margit König, H Daxberger, Evgenia Glogova, Ulrike Pötschger, (unknown), Ánita Lawitschka, (unknown), (unknown), Wolfgang Holter, Oskar A. Haas, Thomas Lion, Susanne Matthes‐Martin	17
11	Toxicity and outcome of anti-GD₂ antibody ch14.18/CHO in front-line, high-risk patients with neuroblastoma: Final results of the phase III immunotherapy randomisation (HR-NBL1/SIOPEN trial). 2016 ·Journal of Clinical Oncology ·Ruth Ladenstein, Ulrike Pöetschger, Juliet C. Gray, Dominique Valteau‐Couanet, Roberto Luksch, Victoria Castel, Isaac Yaniv, Geneviève Laureys, Martin Elliott, Jean Michon, Cormac Owens, Toby N. Trahair, Godfrey Chi Fung Chan, Ellen Ruud, Henrik Schrøeder, Maja Beck‐Popovic, Evgenia Glogova, G. Schreier, Hans Loibner, Holger N. Lode, (unknown)	13
12	Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases 2015 ·Bone Marrow Transplantation ·Mary Slatter, Heidrun Boztug, Ulrike Pötschger, K-W Sykora, A Lankester, Isaac Yaniv, Petr Sedláček, Evgenia Glogova, Paul Veys, Andrew R. Gennery, Christina Peters, (unknown)	56
13	European Society for Blood and Marrow Transplantation Analysis of Treosulfan Conditioning Before Hematopoietic Stem Cell Transplantation in Children and Adolescents With Hematological Malignancies 2015 ·Pediatric Blood & Cancer ·Heidrun Boztug, Karl‐Walter Sykora, Mary Slatter, Marco Zecca, Paul Veys, Arjan C. Lankester, Andrew J. Cant, Roderick Skinner, Jacek Wachowiak, Evgenia Glogova, Ulrike Pötschger, Christina Peters	26
14	Risk Factors Affecting Outcome of Transplantation in Pediatric Acute Lymphoblastic Leukemia: Results of the International BFM ALL SCT Study 2015 ·Blood ·Adriana Balduzzi, Jean‐Hugues Dalle, Arjan C. Lankester, Isaac Yaniv, Akif Yeşilipek, Petr Sedláček, Marianne Ifversen, Sabina Sufliarska, Marc Bierings, Jacek Wachowiak, Jacek Toporski, Ulrike Pöetschger, Evgenia Glogova, (unknown), Christina Peters	1
15	THE ROLE OF MEGATHERAPY (MGT) AND STEM CELL TRANSPLANTATION (SCT) IN HIGH RISK EWING TUMORS (ET): MORE THAN 30 YEARS OF EBMT ACTIVITY 2014 ·mediaTUM (Technical University of Munich) ·Ruth Ladenstein, D Valteau-Couanet, Evgenia Glogova, H. Juergens, S. Burdach, Jean Michon, H. van den Berg, Ian Lewis, I. Yaniv, Christina Peters	1
16	Development of treatment and clinical results in childhood AML in Austria (1993–2013) 2014 ·memo - Magazine of European Medical Oncology ·Heidrun Boztug, Nora Mühlegger, Evgenia Glogova, Georg Mann, Christian Urban, Bernhard Meister, Klaus Schmitt, Neil D. Jones, Andishe Attarbaschi, Oskar A. Haas, Sabine Strehl, Thomas Lion, Ulrike Pötschger, Franz‐Martin Fink, Helmut Gadner, Michael Dworzak	4
17	No Impact of Total or Myeloid Cd34+ Cell Numbers on Neutrophil Engraftment and Transplantation-Related Mortality after Allogeneic Pediatric Bone Marrow Transplantation 2014 ·Biology of Blood and Marrow Transplantation ·Herbert Pichler, Volker Witt, (unknown), Heidrun Boztug, Evgenia Glogova, Ulrike Pötschger, Susanne Matthes‐Martin, G. Fritsch	7
18	Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia 2014 ·Annals of Hematology ·(unknown), Heidrun Boztug, Marco Zecca, Karl‐Walter Sykora, Paul Veys, Arjan C. Lankester, (unknown), Roderick Skinner, Jacek Wachowiak, Ulrike Pötschger, Evgenia Glogova, Christina Peters	30
19	Modeling Dependent Credit Risks for Application to Off-Site Banking Supervision 2006 ·RePEc: Research Papers in Economics ·Evgenia Glogova, (unknown)	1
20	Determinants of Initial Public Offerings - A European Time-Series Cross-Section Analysis 2002 ·RePEc: Research Papers in Economics ·(unknown), Evgenia Glogova	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact